Menu
Default Alt Text

Spiro Gavaris

President – US Generics

Spiro is responsible for the overall strategy, implementation, and growth of Lupin’s U.S. Generics Business.

Prior to joining Lupin, he gained comprehensive pharma, injectables and biotech experience, most notably serving as the President, Specialty Generics at Mallinckrodt Pharmaceuticals and President, US Injectables at Hikma.

Spiro holds a Bachelor’s degree from Franklin & Marshall College and MBA from New York University Stern School of Business.

Flower big
Smart Guide
Consent to Collection CookieTest

This website uses cookies to enhance your overall web browsing experience, provide you with ads tailored to your interests, and allow us to measure our audience and collect other analytical data about the use of our website.

By clicking "Accept All" you consent to the collection of your personal information (which may include your Consumer Health Data) through 1st and 3rd party cookies (or similar). To edit your cookie preferences, use the options below.

For more information, please visit our Privacy Statement.

Depending on where you live, you may also be able to exercise your right to opt out or withdraw your consent.Do Not Sell/Share My Personal Information.